Paul K. Wotton, President and CEO at ANTARES PHARMA, INC. (ATRS), sold 22,900 shares at $5.10 ($117K) on 2014-01-15, disclosed to the SEC on 2014-01-17.
Scheduled sale ($117k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| VCEL | SELL | 2024-12-05 | $153K | — | Filing → |
| VCEL | SELL | 2023-12-15 | $187K | — | Filing → |
| VCEL | SELL | 2021-05-17 | $505K | — | Filing → |